Scholars Central

Conference abstractPublished 1 Oct 2018

The neuroprotective effect of glutamate receptors group II agonists in an animal model of birth asphyxia is connected with inhibition of caspase independent apoptosis

Authors: Ewelina Bratek, A Ziembowicz, E Salinska

Mossakowski Medical Research Centre-Polish Academy of Sciences, Poland

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Statement of the Problem: Hypoxic-ischemic encephalopathy is one of the leading causes of neonatal mortality and permanent neurological disability worldwide. It was shown recently that mGluR2/3 activation before or after ischemic insult results in neuroprotection, but the exact mechanism of this effect is not clear. Aim: The aim of present study was to investigate whether glutamate receptors group II agonists (mGluR2/3) activation after hypoxia-ischemia reduces brain damage and inhibits apoptotic processes. Methodology: We used an animal model of Hypoxia-Ischemia (H-I) on 7-day old rat pups. Animals underwent unilateral common carotid artery ligation combined with 75 min hypoxia at 7.4% oxygen. Control pups were sham-operated (anaesthetized and left common carotid artery dissected, but not ligated). Animals were injected intraperitoneally with mGluR2 (LY 379268) and mGluR3 (NAAG) agonists, 1 hour or 6 hours after H-I (5 mg/kg of body weight). We examined the weight deficit of the ischemic brain hemisphere and the expression of caspase independent apoptosis factors (AIF, HTR/OMI and endonuclease G). The expression of trophic factors GDNF, BDNF and TGF-beta was also measured. Results: Our results show that application of each agonist decreased brain tissue weight loss in ischemic hemisphere independently on the time of application (from 40% in H-I to 15-20% in treated). Both agonists of mGluR2/3 applied 1 hour or 6 hours after H-I decreased expression of AIF, HTR/OMI and endonuclease G proteins compared to untreated H-I. The mGluR2/3 agonists application decreased expression of TGF-beta and increased BDNF and GDNF in the ischemic hemisphere compared to H-I. Conclusion: This study demonstrated the neuroprotective effect of mGluR 2/3 agonists on neonatal hypoxic-ischemic brain injury. Presented data suggest that this effect is connected with decreasing apoptosis.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Neuropsychology: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Neuropsychology: Open Access
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Ewelina Bratek”
  • BylineArticles whose byline prints “A Ziembowicz”
  • BylineArticles whose byline prints “E Salinska”